We are continually working to progress next generation gene therapy treatments for life-threatening diseases. We are developing programs for rare genetic diseases with both systemic and local delivery.
We’re determined to provide life-changing DNA-based therapies.
Tyris’ pipeline currently focuses on several high unmet need genetic diseases and can be applied on any therapeutic area where current gene therapy platforms have shown strong limitations.
Liver
Kidney
Skin
Brain
Lungs
Eyes
Promising further applications of our technology platform to fuel innovation in more prevalent therapeutic approaches.
Car-T’s
Vaccines
Antibodies
Gene editing
Partnership
At Tyris we are committed to develop our own pipeline of transformative non-viral gene therapies. With that purpose in mind, we are also open to combine our expertise, collaborating with external partners to progress jointly our science and deliver transformative medicines to patients.
